Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Magnesium may shield against colon cancer in genetically At-Risk individuals

NCT ID NCT01105169

First seen Feb 26, 2026 · Last updated Jun 17, 2026 · Updated 17 times

Summary

This study tested whether taking magnesium supplements could reduce the risk of colorectal cancer in people with a specific genetic makeup. Researchers gave 250 participants either magnesium or a placebo for 12 weeks and measured changes in colon tissue markers linked to cancer development. The goal was to see if adjusting calcium and magnesium levels in the diet could help prevent polyps and cancer, especially for those with a higher genetic risk.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37203, United States

Conditions

The condition(s) this trial relates to.

colorectal adenoma colorectal cancer colorectal neoplasm hyperplastic polyp

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.